These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3921945)

  • 21. [Clinical course of advanced microvascular complications in diabetic patients undergoing long-term treatment with the subcutaneous insulin infusion pump].
    Calle Pascual AL; Charro Salgado AL
    Med Clin (Barc); 1983 Dec; 81(20):904-7. PubMed ID: 6664146
    [No Abstract]   [Full Text] [Related]  

  • 22. New modes of insulin administration: do they have a role in clinical diabetes?
    Rizza RA
    Ann Intern Med; 1986 Jul; 105(1):126-9. PubMed ID: 3087254
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy.
    Lauritzen T
    Dan Med Bull; 1985 May; 32(2):104-18. PubMed ID: 3924487
    [No Abstract]   [Full Text] [Related]  

  • 24. Controlled drug delivery in the treatment of diabetes mellitus.
    Irsigler K; Kritz H; Lovett RG
    Crit Rev Ther Drug Carrier Syst; 1985; 1(3):189-280. PubMed ID: 3912064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of beneficial effects of strict glycemic control on diabetic vascular complications--a prospective study with artificial devices.
    Shichiri M; Kawamori R; Goriya Y; Kikuchi M; Bando K; Abe H
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():719-22. PubMed ID: 6680548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic ketoacidosis caused by exposure of insulin to low temperature.
    Minuto N; Tambroni B; Vannati M; Emmanuele V; Russo C; Lorini R; d'Annunzio G
    Diabetes Technol Ther; 2010 Sep; 12(9):745-6. PubMed ID: 20687866
    [No Abstract]   [Full Text] [Related]  

  • 27. Diabetic retinopathy, nephropathy and neuropathy. Generalized vascular damage in insulin-dependent diabetic patients.
    Jensen T; Deckert T
    Horm Metab Res Suppl; 1992; 26():68-70. PubMed ID: 1490695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperkalaemia, ketoacidosis and subcutaneous or intravenous insulin infusions.
    MacRury SM; Small M; MacCuish AC
    Diabetes Res; 1987 Jul; 5(3):153-5. PubMed ID: 3117474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy.
    Tamborlane WV; Puklin JE; Bergman M; Verdonk C; Rudolf MC; Felig P; Genel M; Sherwin R
    Diabetes Care; 1982; 5 Suppl 1():58-64. PubMed ID: 7188047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
    Dogan ADA; Jørgensen UL; Gjessing HJ
    J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
    [No Abstract]   [Full Text] [Related]  

  • 31. Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps.
    Teutsch SM; Herman WH; Dwyer DM; Lane JM
    N Engl J Med; 1984 Feb; 310(6):361-8. PubMed ID: 6419110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Workshop VIII--Retinopathy, nephropathy, neuropathy, and tight control.
    Lebovitz HE; Vinik AI
    Am J Med; 1991 Feb; 90(2A):80S-84S. PubMed ID: 1994725
    [No Abstract]   [Full Text] [Related]  

  • 33. Lessons from the Diabetes Control and Complications Trial.
    Santiago JV
    Diabetes; 1993 Nov; 42(11):1549-54. PubMed ID: 8405693
    [No Abstract]   [Full Text] [Related]  

  • 34. Continuous subcutaneous insulin infusion systems. A new approach to management of type I diabetes.
    Clarke WL
    Postgrad Med; 1983 Jan; 73(1):319-25. PubMed ID: 6848995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Ganes T; Kierulf P; Smeland E; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1986 Nov; 293(6556):1195-9. PubMed ID: 3096429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic renal-retinal syndrome: does tight control help?
    Cowan CL
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):86-9. PubMed ID: 3551259
    [No Abstract]   [Full Text] [Related]  

  • 37. Implications of the diabetes control and complications trial for persons with non-insulin-dependent diabetes mellitus.
    Vinik AI; Richardson DW
    South Med J; 1997 Mar; 90(3):268-82. PubMed ID: 9076296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy.
    Lauritzen T; Frost-Larsen K; Larsen HW; Deckert T
    Diabetes; 1985 Aug; 34 Suppl 3():74-9. PubMed ID: 4018423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ketoacidosis during ambulatory treatment by continuous subcutaneous infusion of insulin. Possible role of catheter infection].
    Leguerrier AM; Allannic H; Lorcy Y
    Presse Med; 1984 Apr; 13(16):1008. PubMed ID: 6232520
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.
    Pickup J; Keen H
    Diabetes Care; 2002 Mar; 25(3):593-8. PubMed ID: 11874953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.